Clarity Pharmaceuticals (Clarity Pharmaceuticals) Accounts Payable & Accrued Expense : $2.67 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Clarity Pharmaceuticals Accounts Payable & Accrued Expense?

Clarity Pharmaceuticals's quarterly accounts payable & accrued expense declined from Dec. 2022 ($4.69 Mil) to Jun. 2023 ($4.52 Mil) and declined from Jun. 2023 ($4.52 Mil) to Dec. 2023 ($2.67 Mil).

Clarity Pharmaceuticals's annual accounts payable & accrued expense increased from . 20 ($0.00 Mil) to Jun. 2022 ($4.77 Mil) but then declined from Jun. 2022 ($4.77 Mil) to Jun. 2023 ($4.52 Mil).

Clarity Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Clarity Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarity Pharmaceuticals Accounts Payable & Accrued Expense Chart

Clarity Pharmaceuticals Annual Data

Trend

Jun22

Jun23

Accounts Payable & Accrued Expense

4.77

4.52

Clarity Pharmaceuticals Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			1.42	4.77	4.69	4.52	2.67

Clarity Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Clarity Pharmaceuticals (Clarity Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clarity Pharmaceuticals Ltd (OTCPK:CLRPF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

CU6:Australia

Address

4 Cornwallis Street, National Innovation Centre, Eveleigh, Sydney, NSW, AUS, 2015

Website

https://www.claritypharmaceuticals.com

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.